View Author
patient expression leukemia cd 34 myeloid myeloid leukemia sample diagnosis cd 34 reagent blood analysis relapse cd 34ϩcd cells study mutation number disease 34ϩcd blast myelodysplastic syndromes product marrow erasmus mc cytometry group procedure syndrome myelodysplastic signi table fi rst course reagent recovery prognostic tubing chemotherapy bone marrow marker antibody hpc-a products leukemic treatment compartment level hpc-a mrd levels result figure department netherland selection 1 vial detection antigen erasmu therapy flow cytometry course lineage nod /scid mice population prognostic signi ficance cd 34ϩcd compartment outcome remission aml patients hematology ficance tubing sets aberrancie hpc-a product myeloblast frequency clinimac progenitor children t-cell depletion efficiency br j haematol selection procedures capacity
6 Most Recent Publications
|
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: Implications for personalized medicine
(Article)
Bachas, C. Schuurhuis, G.J. Haas, V. de Assaraf, Y.G. Kaspers, G.J. Cloos, J. Hollink, I.H.I.M. Kwidama, Z.J. Goemans, B.F. Zwaan, C.M. Heuvel-Eibrink, M.M. van den Bont, E.S.J.M. de Reinhardt, D. Creutzig, U. |
2010-10-14
|
|
Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
(Article)
Velden, V.H.J. van der Sluijs-Geling, A. van der Wering, E.R. van Dongen, J.J.M. van Gibson, B. Marvelde, J.G. te Hoogeveen, P.G. Hop, W.C.J. Wheatley, K. Bierings, M. Schuurhuis, G.J. Graaf, S.S.N. de |
2010-09-01
|
|
Methylation patterns in CD34 positive chronic myeloid leukemia blast crisis cells
(Article)
Janssen, J.J.W.M. Denkers, F. Valk, P.J.M. Cornelissen, J.J. Schuurhuis, G.J. Ossenkoppele, G.J. |
2010-06-01
|
|
Standardization of flow cytometry in myelodysplastic syndromes: Report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes
(Article)
Loosdrecht, A.A. van de Alhan, C. Ireland, R. Jansen, J.H. Kern, W. Malcovati, L. Marvelde, J.G. te Mufti, G.J. Ogata, K. Orfao, A. Ossenkoppele, G.J. Porwit, A. Béné, M.C. Preijers, F.W. Richards, S.J. Schuurhuis, G.J. Subirá, D. Valent, P. Velden, V.H.J. van der Vyas, P. Westra, A.H. Witte, T. de Wells, D.A. Della Porta, M.G. Loken, M.R. Westers, T.M. Dräger, A.M. Feuillard, J. Font, P. Germing, U. Haase, D. Homburg, C.H. |
2009-08-01
|
|
Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products
(Article)
Braakman, E. Schuurhuis, G.J. Preijers, F.W. Voermans, C. Theunissen, K. Riet, I. van Fibbe, W.E. Slaper-Cortenbach, I. |
2008-01-29
|
|
The novel AML stem cell-associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells
(Article)
Rhenen, A. van Dongen, G.A.M.S. van Kelder, A.L. Rombouts, E.J. Feller, N. Moshaver, B. Walsum, M.S.-V. Zweegman, S. Ossenkoppele, G.J. Schuurhuis, G.J. |
2007-10-01
|
